UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 90 filers reported holding UROGEN PHARMA LTD in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $622,000 | +229.1% | 71,392 | +258.5% | 0.00% | – |
| Q4 2021 | $189,000 | -84.2% | 19,912 | -72.0% | 0.00% | -100.0% |
| Q3 2021 | $1,195,000 | +20.1% | 71,045 | +9.0% | 0.00% | 0.0% |
| Q2 2021 | $995,000 | +247.9% | 65,179 | +343.7% | 0.00% | – |
| Q1 2021 | $286,000 | -44.9% | 14,690 | -49.0% | 0.00% | – |
| Q4 2020 | $519,000 | -5.3% | 28,819 | +1.4% | 0.00% | – |
| Q3 2020 | $548,000 | -17.2% | 28,423 | +12.2% | 0.00% | -100.0% |
| Q2 2020 | $662,000 | +49.8% | 25,328 | +2.3% | 0.00% | – |
| Q1 2020 | $442,000 | -36.8% | 24,749 | +18.1% | 0.00% | -100.0% |
| Q4 2019 | $699,000 | +48.7% | 20,957 | +6.3% | 0.00% | – |
| Q3 2019 | $470,000 | +114.6% | 19,720 | +223.7% | 0.00% | – |
| Q2 2019 | $219,000 | – | 6,093 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,111,050 | $9,099,000 | 4.23% |
| GREAT POINT PARTNERS LLC | 873,424 | $7,153,000 | 1.72% |
| Wildcat Capital Management, LLC | 533,139 | $4,366,000 | 1.45% |
| Opaleye Management Inc. | 238,670 | $1,955,000 | 0.88% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,949,489 | $24,156,000 | 0.44% |
| Annandale Capital, LLC | 84,331 | $691,000 | 0.27% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $206,000 | 0.18% |
| RTW INVESTMENTS, LP | 857,464 | $7,023,000 | 0.18% |
| Harel Insurance Investments & Financial Services Ltd. | 1,025,611 | $8,400,000 | 0.18% |
| BENDER ROBERT & ASSOCIATES | 41,131 | $337,000 | 0.13% |